Literature DB >> 27637302

The History of Antithrombotic Therapy: The Discovery of Heparin, the Vitamin K Antagonists, and the Utility of Aspirin.

Robert I Handin1.   

Abstract

The administration of intravenous heparin to postoperative patients by Barritt and Jordan reduced the incidence of fatal and nonfatal pulmonary embolism and established heparin as the standard for parenteral anticoagulation. The coumarin family of vitamin K antagonists quickly became the standard for long-term oral anticoagulation. Aspirin became a widely used antithrombotic agent after the discovery that chronic oral administration reduced the incidence of secondary strokes and myocardial infarction. This article gives a brief history of antithrombotic therapy, including the discovery of heparin, the vitamin k antagonists, and the utility of aspirin.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antithrombotic therapy; Aspirin; Heparin; Vitamin K antagonists

Mesh:

Substances:

Year:  2016        PMID: 27637302     DOI: 10.1016/j.hoc.2016.06.002

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  8 in total

Review 1.  The role of aspirin and inflammation on reproduction: the EAGeR trial 1.

Authors:  Lindsay D Levine; Tiffany L Holland; Keewan Kim; Lindsey A Sjaarda; Sunni L Mumford; Enrique F Schisterman
Journal:  Can J Physiol Pharmacol       Date:  2018-12-18       Impact factor: 2.273

2.  Horizons of Heparin Therapy in COVID-19 and Pandemic-Related Diseases.

Authors:  M V Kondashevskaya
Journal:  J Evol Biochem Physiol       Date:  2022-05-16       Impact factor: 1.621

3.  Switching from vitamin K antagonists to direct oral anticoagulants in non-valvular atrial fibrillation patients: Does low time in therapeutic range affect persistence?

Authors:  Myrthe M A Toorop; Qingui Chen; Marieke J H A Kruip; Felix J M van der Meer; Melchior C Nierman; Laura Faber; Lies Goede; Suzanne C Cannegieter; Willem M Lijfering
Journal:  J Thromb Haemost       Date:  2021-11-23       Impact factor: 16.036

4.  Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells.

Authors:  Wenjia Zhang; Jing Su; Huadan Xu; Shanshan Yu; Yanan Liu; Yong Zhang; Liankun Sun; Ying Yue; Xiaoli Zhou
Journal:  PLoS One       Date:  2017-06-15       Impact factor: 3.240

Review 5.  Impact of Natural Compounds on Neurodegenerative Disorders: From Preclinical to Pharmacotherapeutics.

Authors:  Mehdi Sharifi-Rad; Chintha Lankatillake; Daniel A Dias; Anca Oana Docea; Mohamad Fawzi Mahomoodally; Devina Lobine; Paul L Chazot; Begum Kurt; Tugba Boyunegmez Tumer; Ana Catarina Moreira; Farukh Sharopov; Miquel Martorell; Natália Martins; William C Cho; Daniela Calina; Javad Sharifi-Rad
Journal:  J Clin Med       Date:  2020-04-08       Impact factor: 4.241

6.  Exploring the Mechanism of Aspirin in the Treatment of Kawasaki Disease Based on Molecular Docking and Molecular Dynamics.

Authors:  Li Xiong; Junfeng Cao; Yixin Qiu; Yinyin Fu; Siyi Chen; Mengjia He; Shengyan Chen; Wei Xie; Xingyu Yang; Chaochao Wang; Mei Wu; Hengxiang Xu; Yijun Chen; Xiao Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-12       Impact factor: 2.650

7.  Aspirin Exerts Its Antitumor Effect in Esophageal Squamous Cell Carcinoma by Downregulating the Expression of ATAD2 and KIF4A.

Authors:  Man Zhang; Zhenzhen Ren; Xianzeng Wang; Cong Liu; Zhaoyang Zheng; Junwei Zhao; Hongchun Liu
Journal:  Anal Cell Pathol (Amst)       Date:  2022-08-21       Impact factor: 4.133

Review 8.  All about pain pharmacology: what pain physicians should know.

Authors:  Kyung-Hoon Kim; Hyo-Jung Seo; Salahadin Abdi; Billy Huh
Journal:  Korean J Pain       Date:  2020-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.